Eiger BioPharmaceuticals, Inc. Quarterly Return On Equity in % from Q3 2014 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Return On Equity for the quarter ending December 31, 2023 was -870 %, a 650% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2023 was -870 %, a 650% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2022 was -116 %, a 240% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Return On Equity for 2021 was -34.2 %, a 62% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -870 -754 -650% Oct 1, 2023 Dec 31, 2023
Q3 2023 -332 -226 -212% Jul 1, 2023 Sep 30, 2023
Q2 2023 -208 -110 -113% Apr 1, 2023 Jun 30, 2023
Q1 2023 -143 -49.4 -53% Jan 1, 2023 Mar 31, 2023
Q4 2022 -116 -81.8 -240% Oct 1, 2022 Dec 31, 2022
Q3 2022 -106 -77 -261% Jul 1, 2022 Sep 30, 2022
Q2 2022 -97.8 -74.7 -324% Apr 1, 2022 Jun 30, 2022
Q1 2022 -93.2 -71.1 -322% Jan 1, 2022 Mar 31, 2022
Q4 2021 -34.2 +55.7 +62% Oct 1, 2021 Dec 31, 2021
Q3 2021 -29.5 +71.1 +70.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -23.1 +92 +79.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -22.1 +83.2 +79% Jan 1, 2021 Mar 31, 2021
Q4 2020 -89.8 +15.4 +14.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -101 +0.19 +0.19% Jul 1, 2020 Sep 30, 2020
Q2 2020 -115 -0.74 -0.65% Apr 1, 2020 Jun 30, 2020
Q1 2020 -105 +15.9 +13.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -105 +22.3 +17.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -101 +54.8 +35.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -114 +42.4 +27% Apr 1, 2019 Jun 30, 2019
Q1 2019 -121 +106 +46.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -127 +68.5 +35% Oct 1, 2018 Dec 31, 2018
Q3 2018 -156 +13.6 +8.04% Jul 1, 2018 Sep 30, 2018
Q2 2018 -157 -27.7 -21.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -227 -111 -96% Jan 1, 2018 Mar 31, 2018
Q4 2017 -196 -97.2 -98.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -169 -103 -156% Jul 1, 2017 Sep 30, 2017
Q2 2017 -129 -70.2 -119% Apr 1, 2017 Jun 30, 2017
Q1 2017 -116 -46.3 -66.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -98.9 -58.6 -145% Oct 1, 2016 Dec 31, 2016
Q3 2016 -66.2 -58.2 -735% Jul 1, 2016 Sep 30, 2016
Q2 2016 -58.8 -48.5 -474% Apr 1, 2016 Jun 30, 2016
Q1 2016 -69.7 -79.9 -781% Jan 1, 2016 Mar 31, 2016
Q4 2015 -40.3 -37.1 -1134% Oct 1, 2015 Dec 31, 2015
Q3 2015 -7.92 +12.9 +62% Jul 1, 2015 Sep 30, 2015
Q2 2015 -10.2 Apr 1, 2015 Jun 30, 2015
Q1 2015 10.2 Jan 1, 2015 Mar 31, 2015
Q4 2014 -3.27 Oct 1, 2014 Dec 31, 2014
Q3 2014 -20.8 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.